Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland.
In: European Journal of Clinical Microbiology & Infectious Diseases, Jg. 39 (2020-06-01), Heft 6, S. 1185-1191
Online
academicJournal
Zugriff:
We evaluated the in vitro effectiveness of temocillin and several commonly used antimicrobials against Enterobacterales bacteria in isolates from Polish patients. We tested 400 isolates: 260 extended-spectrum β-lactamase (ESBL)- and/or ampC β-lactamase (AmpC)-producing isolates; 40 Klebsiella pneumoniae carbapenemase (KPC)-producing isolates; and 100 ESBL-, AmpC-, and KPC-negative isolates. The minimal inhibitory concentrations (MICs) of temocillin and 16 other antimicrobials were determined by reference microdilution. We also determined the activities of fosfomycin and ceftazidime/avibactam in KPC-producing isolates. The antibiotic sensitivities were interpreted according to EUCAST, BSAC, and CLSI criteria. Overall, 91% of the isolates were susceptible to temocillin using the urinary tract infection breakpoint (≤ 32 mg/L), and 61.8% were susceptible using the systemic infection breakpoint (≤ 8 mg/L). Meropenem and imipenem were the most active drugs (MIC50 values of 0.06 and 0.5 mg/L, respectively). Colistin and ertapenem (both MIC50 = 0.12 mg/L) were less active than meropenem or imipenem, but some strains were 77% susceptible to each of them. Among the KPC-producing isolates, 42.5% had MIC values of ≤ 32 mg/L (urinary tract infection breakpoint), but 100% were resistant to temocillin (systemic infection breakpoint). Ceftazidime/avibactam was active against 100% of the KPC-producing isolates, and fosfomycin was active against 40%. The empirical susceptibility rate observed among the urinary isolates suggests that temocillin may be considered as an alternative to carbapenems in the absence of KPC-producing bacteria. With regard to isolates from other sources, temocillin might be useful as a documented therapy agent or an empirical treatment in hospitals with a low prevalence of ESBL/AmpC-producing strains. [ABSTRACT FROM AUTHOR]
Titel: |
Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland.
|
---|---|
Autor/in / Beteiligte Person: | Kuch, Alicja ; Zieniuk, Bartłomiej ; Żabicka, Dorota ; Van de Velde, Sebastien ; Literacka, Elżbieta ; Skoczyńska, Anna ; Hryniewicz, Waleria |
Link: | |
Zeitschrift: | European Journal of Clinical Microbiology & Infectious Diseases, Jg. 39 (2020-06-01), Heft 6, S. 1185-1191 |
Veröffentlichung: | 2020 |
Medientyp: | academicJournal |
ISSN: | 0934-9723 (print) |
DOI: | 10.1007/s10096-020-03844-5 |
Schlagwort: |
|
Sonstiges: |
|